Does medical research with illicit drugs benefit patients? Overview: Studies document potential medicinal effects of illicit substances, but questions remain / Monica Dybuncio and Ryan Jaslow -- The possibilities for innovative medical treatments are unlimited / Phillip Francis -- Drugs from the 1960s are the focus of new research / Denis Campbell -- Creating contemporary criteria for drug evaluation and policies / Veljko Dubljević -- Challenges with medical tourism / Jennifer Whitlock -- Is the current drug approval and regulation process the best option for patients? Overview: A century of regulated drug development has improved health outcomes and created guidelines for innovation and new therapies / US Food and Drug Administration -- The 2018 FDA approvals benefit patients / Monique Ellis -- The medical impact of recent advances in technology / Monique Ellis -- Stem cells have changed everything, but stem cell research was hindered by research bans / Michael White -- The drug approval process is confusing / Comment Central -- Government regulation adds costs and red tape, weighing down scientific innovation / Dean Baker -- Does current regulation of illicit drugs inhibit medical innovation? Overview: Research in drug innovation may not be aimed in the right direction / Christopher-Paul Milne and Kenneth J. Kaitin -- Illegal drugs will be a catalyst for dramatic scientific innovation / David Nutt -- We need to study and collect data on medical marijuana / David Trilling -- Removing long-time barriers to research and medical innovation / David Nutt -- Science defines medical cannabis today / Dr. C.M. Helm-Clark -- Historically, medical experiments led to accidental addiction / Stevyn Colgan -- Should the medical use of illicit drugs be exempt from legal repercussions? Overview: Questions for consideration in developing drug policy / Mark A.R. Kleiman, Jonathan P. Caulkins, Angela Hawken, and Beau Kilmer -- Can Employees smoke marijuana on the job? / The Emplawyerologist Firm -- Legalizing cannabis could have positive benefits / Teri Moore -- Misuse and abuse of legal stimulants requires analysis and new policy / Steve Sussman, Mary Ann Pentz, Donna Spruijt-Metz, and Toby Miller -- Psychoactive substances available in cyberspace cause harm / Eduardo Cinosi [and six others].
|
